Rhenman & Partners Asset Management AB
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1599882
Stockholm, V7
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,078,760
-$20,085,224 QoQ
Shares Held
27,390
-43.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#232
of 1,322 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. REGN ranks #2 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
87,440 | $21,070,416 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
27,390 | $17,078,760 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
290,500 | $16,622,410 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
684,250 | $16,599,905 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
139,205 | $16,296,729 | |
| 6 | INSM |
INSMED Inc
|
151,960 | $16,201,975 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
63,050 | $15,432,748 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,685 | $15,242,160 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,078,760 | 27,390 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $37,163,984 | 48,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $47,392,818 | 61,400 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,297,947 | 36,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,542,500 | 27,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,136,802 | 31,750 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,955,724 | 43,457 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $40,998,360 | 39,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,632,960 | 32,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,013,407 | 34,300 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,253,310 | 39,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,918,400 | 40,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,148,900 | 35,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $29,169,285 | 35,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,695,130 | 37,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,043,840 | 32,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,275,820 | 14,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $19,904,970 | 28,500 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $13,963,500 | 25,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,462,800 | 20,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $19,324,400 | 40,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $12,595,050 | 22,500 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $7,795,625 | 12,500 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||